Aurora Cannabis Inc. ($ACB) Stock Forecast: Down 22.7% Today

What is Aurora Cannabis Inc.?

Aurora Cannabis (ACB) is a Canadian medical marijuana firm with a global presence, recently revealing growth in adjusted EBITDA and global medical cannabis net revenue.

Why is Aurora Cannabis Inc. going down?

ACB stock is down 22.7% on Jun 18, 2025 16:45

• The decline in ACB stock is linked to lower-than-expected demand in the global market, evident from the Q4 earnings missing estimates.
• Despite improved adjusted EBITDA and global medical cannabis net revenue, the market reacted negatively due to reported quarterly loss per share.
• The stock fall during pre-market trading, dropping by 20.1% post fourth-quarter results, added to the negative sentiment surrounding ACB.
• Concerns about future growth and operational efficiency are likely driving investor worries, contributing to the downward trend in ACB stock.

ACB Price Chart

ACB Technical Analysis

ACB News

Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market - Aurora Cannabis ( NASDAQ:ACB )

Aurora posted a 619% jump in adjusted EBITDA, reaching CA 16.7 million in Q4 2025. Global medical cannabis net revenue surged 48% to CA 67.8 million, making up 75% of total net revenue. Last Chance: See the "Power Pattern" That Delivered Winners 9 Out of the Last 10 Summers. Get The Details Here

https://www.benzinga.com/cannabis/25/06/45997534/canadian-medical-marijuana-firm-aurora-cannabis-expects-weak-demand-in-international-market

Aurora Cannabis Inc. ( ACB ) Misses Q4 Earnings Estimates

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -36.36% and 1.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2510324/aurora-cannabis-inc-acb-misses-q4-earnings-estimates

Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Aurora Cannabis ( NASDAQ:ACB ) , Bitdeer Technologies ( NASDAQ:BTDR )

U.S. stock futures were higher this morning, with the Dow futures gaining more than 50 points on Wednesday. Shares of Aurora Cannabis Inc. ACB fell 20.1% to $4.70 in pre-market trading following fourth-quarter results. Aurora Cannabis posted a quarterly loss of 24 cents per share.

https://www.benzinga.com/trading-ideas/movers/25/06/45993739/aurora-cannabis-bitdeer-technologies-group-and-other-big-stocks-moving-lower-in-wednesdays-p

Trending Today

Ondo ($ONDO) Crypto Forecast: Up 5.4% Today

Visa Inc. ($V) Stock Forecast: Down 5.1% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 5.2% Today

Mastercard Incorporated ($MA) Stock Forecast: Down 5.1% Today

Applovin Corporation ($APP) Stock Forecast: Down 5.5% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Up 18.4% Today

Reddit Inc ($RDDT) Stock Forecast: Up 5.0% Today

Carvana Co ($CVNA) Stock Forecast: Up 5.2% Today

Riot Platforms, Inc. ($RIOT) Stock Forecast: Up 5.3% Today

Plug Power Inc. ($PLUG) Stock Forecast: Up 6.6% Today

Aurora Cannabis Inc. Price History

18.05.2025 - ACB Stock was down 22.7%

• The decline in ACB stock is linked to lower-than-expected demand in the global market, evident from the Q4 earnings missing estimates.
• Despite improved adjusted EBITDA and global medical cannabis net revenue, the market reacted negatively due to reported quarterly loss per share.
• The stock fall during pre-market trading, dropping by 20.1% post fourth-quarter results, added to the negative sentiment surrounding ACB.
• Concerns about future growth and operational efficiency are likely driving investor worries, contributing to the downward trend in ACB stock.

04.05.2025 - ACB Stock was up 5.3%

• Recommendation by a notable financial commentator favoring Nvidia over Aurora Cannabis potentially influenced investors to shift focus towards the semiconductor industry, positively impacting ACB's stock.
• The upward trend in ACB's stock value could also be linked to investors seeking growth prospects in the cannabis sector amid evolving regulations and growing market demand.
• The optimistic outlook on ACB may be fueled by market participants anticipating robust financial performance or strategic partnerships in the future, leading to an increase in the stock price.

08.10.2024 - ACB Stock was down 5.6%

• Aurora Cannabis (ACB) reported strong quarterly earnings that exceeded market expectations, but its share price still fell by 18% due to broader sector pressures, with the cannabis sector experiencing a downturn.
• The cannabis sector as a whole took a sharp downturn after Donald Trump's presidential election victory, leading to major players like Aurora Cannabis seeing double-digit declines in their stock prices.
• Despite beating Q2 earnings and revenue estimates, Aurora Cannabis (ACB) still faced a bearish market movement, possibly due to overall sector pressures and external factors like political events impacting the industry.

25.01.2025 - ACB Stock was down 5.3%

• Analysts foresee a 25.67% upside in ACB stock, potentially influencing bullish sentiment among investors.
• Market response may have been bearish given the disparity between analyst projections and the company's actual performance.
• Investor caution regarding industry volatility and regulatory uncertainties could be weighing negatively on ACB's stock.
• The gap between analyst optimism and market performance may have prompted profit-taking and a bearish trend in ACB stock.

05.01.2025 - ACB Stock was up 44.5%

• Aurora Cannabis (ACB) experienced a strong bullish movement today.
• The surge in ACB stock price can be attributed to the company's impressive Q3 earnings report, with record-breaking net revenue of CA$88.2M.
• The significant increase in adjusted EBITDA by 316% to CA$23.1M and improved gross margin of 65% showcase the company's operational efficiency and cost management strategies.
• The positive market response indicates investor confidence in Aurora Cannabis's financial performance and growth prospects, driving the bullish movement in the stock price.

05.01.2025 - ACB Stock was up 47.6%

• Aurora Cannabis (ACB) stock surged by 45% following the release of its Q3 earnings report, which showcased record medical cannabis sales and significant growth in net revenue.
• The strong financial performance, including a 316% increase in adjusted EBITDA and improved gross margin, contributed to the bullish sentiment surrounding ACB stock.
• Additionally, the delay in U.S. tariffs on Canadian imports further boosted the cannabis sector, leading to positive market movement for Aurora Cannabis and other companies like Canopy Growth (CGC), Tilray (TLRY), and Cronos (CRON).

20.02.2025 - ACB Stock was up 6.0%

• The bullish movement in ACB's stock today is possibly linked to the favorable sentiment surrounding the global legalization of cannabis, positioning the company well to benefit from this trend.
• A comparison with Concentra Group suggests that ACB is excelling within the medical stocks sector, potentially enhancing investor confidence in the stock.
• ACB's extensive regulatory expertise and robust manufacturing capabilities likely played a part in its strong performance, attracting investors interested in the expanding medical cannabis market.

20.02.2025 - ACB Stock was up 7.5%

• ACB's bullish movement today can be attributed to the discovery of a new source of genetic resistance against powdery mildew in cannabis sativa, showcasing the company's commitment to innovation and product development.
• The company's strategic positioning in the rapidly evolving medical cannabis landscape, with EU GMP-certified manufacturing facilities and advanced genetics, has also contributed to investor confidence and interest in ACB.
• As the global legalization wave for cannabis continues to gain momentum, ACB's strong performance and focus on developing powdery mildew-resistant plants further solidify its position as a key player in the industry, attracting potential investors seeking growth opportunities in the sector.

10.01.2025 - ACB Stock was up 7.4%

• Aurora Cannabis (ACB) stock saw a remarkable 45% increase following its strong performance in Q3. The report highlighted impressive medical cannabis sales and robust financial results.
• Surpassing analyst expectations by 50% in earnings and 9.50% in revenue, the company's earnings report instilled confidence in investors, propelling the stock price upwards.
• Positive market sentiment within the cannabis industry was reinforced by a recent development involving a delay in U.S. tariffs on Canadian goods, further elevating ACB's success.
• Aurora's strategic focus on efficiency, cost-cutting measures, and heightened gross margins also significantly influenced the market's positive response, hinting at a potential resurgence for the company in the competitive cannabis market.

27.01.2025 - ACB Stock was down 5.9%

• The decline in ACB stock today may be due to investors taking profits following a period of gains.
• Analysts have a positive outlook on ACB's future performance, estimating a potential upside of 25.67% according to Wall Street projections.
• The discrepancy between the stock's decline and analysts' optimistic forecasts suggests short-term market trends rather than lingering concerns over the company's prospects.
• Given the volatility of the cannabis industry, investors are advised to monitor regulatory updates and market shifts when considering investments in ACB stock.

17.02.2025 - ACB Stock was up 5.3%

• ACB's upward movement may be linked to positive internal developments like robust financial results and strategic collaborations.
• In comparison with Concentra Group (CON), ACB's strong performance in the medical segment could be enhancing investor sentiment towards the stock.
• The optimistic trajectory of ACB reflects the increasing confidence in the cannabis sector, leading to a rise in stock values industry-wide.

18.05.2025 - ACB Stock was down 19.3%

• ACB stock experienced a significant bearish movement of 20.1% in pre-market trading.
• The fourth-quarter results of Aurora Cannabis showed a quarterly loss of 24 cents per share, which disappointed investors.
• The negative earnings report likely contributed to the sharp decline in ACB stock price as investors reacted to the company's financial performance.
• The overall bearish sentiment in the market could have also played a role in the downward movement of ACB stock.